CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy

Gao-Shu Zheng1,2, Yan-Min Tan1, Yuan-Yuan Shang1

  • 1The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, Shandong, China.

Abstract

Insights

Cell death-inducing DFF45-like effector C (CIDEC) contributes to diabetic nephropathy (DN). Silencing CIDEC in rats improved insulin resistance, reduced kidney damage, and inhibited apoptosis, suggesting a therapeutic target for DN.

Area of Science:

  • Nephrology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Cell death-inducing DFF45-like effector C (CIDEC) is implicated in insulin resistance and diabetic nephropathy (DN) progression.
  • Understanding CIDEC's role in DN pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of CIDEC in the regulation of DN.
  • To elucidate the underlying mechanisms by which CIDEC influences DN progression.

Main Methods:

  • A type 2 diabetic rat model was established using a high-fat diet and streptozotocin.
  • Histopathological analysis, western blot, and gene silencing were employed to study CIDEC's effects.
  • The impact of CIDEC on high glucose-stimulated renal tubular epithelial cells was assessed.

Main Results:

  • Diabetic rats exhibited metabolic disturbances, kidney damage, increased apoptosis, and fibrosis.
  • CIDEC gene silencing ameliorated metabolic disorders, improved renal function, reduced apoptosis, and inhibited fibrosis.
  • In vitro, high glucose increased CIDEC expression, apoptosis, and decreased autophagy; CIDEC silencing reversed these effects.
  • Molecularly, CIDEC silencing reduced early growth response factor 1 (EGR1) and increased adipose triglyceride lipase (ATGL) expression.

Conclusions:

  • CIDEC gene silencing demonstrates a protective effect against DN progression.
  • Restoring autophagy and inhibiting apoptosis, potentially via EGR1 and ATGL modulation, are key mechanisms.
  • Targeting CIDEC presents a promising therapeutic strategy for managing diabetic nephropathy.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.7K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.8K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.2K